Table 4.
Available techniques for induction of hepatocellular carcinoma in relation to temporal and technical aspects as well as major advantages and disadvantages (summarized from[92])
| Method and specification | Time to HCC short (+) to long (+++) | Technical efforts low (+) to high (+++) | Major “Pros” (+) vs “Contras” (-) |
| Chemotoxic agents linked models | |||
| Diethylnitrosamine | ++ | + | (+) good combination options with other methods |
| 9,10-dimethyl-1,2-benzanthracene | (-) time to HCC not easily predictable | ||
| Direct implantation of tumor cells or tissue | |||
| Heterotopic/orthotopic | + | +/++ | (+) heterotopic xenografts are often and easily done |
| (+) syngeneic orthotopic models better reflect the natural liver microenvironment | |||
| Syngeneic/xenografts | (-) xenografts need immunocompromised mice | ||
| (-) orthotopic tumor implants need surgical and imaging experience | |||
| Genetically engineered mouse models | |||
| Mouse embryo manipulation | ++/+++ | +++ | (+) hepatocarcinogenesis can be analyzed stepwise |
| Cre-Lox recombination | (-) effects of manipulated gene(s) could have heterogeneous latency and genetic penetrance | ||
| Hydrodynamic injection | |||
| CRISPR-Cas9 | |||
| Humanized mouse models | |||
| Immunologically humanized mice | +++ | +++ | (+) immunotherapeutical issues can be studied based on human cell lines in mice |
| Genetically humanized mice | (-) establishment difficult due to engraftment failure and development of stable stem cell-derived hepatocytes | ||
HCC: Hepatocellular carcinoma.